Abstract
Type 1 diabetes (T1D) is the result of an immunological desbalance leading to beta cell destruction by activated autoreactive T cells and their cytokines. Although until now, there are no effective therapy direct to diabetic pathogenesis that prevents the disease, much has been done aimed at terciary prevention, i.e, intervention at ongoing immunological process to preserve beta cell mas…